Reference number : 236-2017-2018-Q1-00596, amendment number : , agreement type : G, recipient legal name : Castellucci, Lana, recipient country : CA, recipient province : ON, recipient city : Ottawa, recipient postal code : K1Y 4E9, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 1231650.0, agreement start date : 2017-04-01, agreement end date : 2022-03-31, description english : Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Venous Thromboembolism: A randomised controlled trial, description french : Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Venous Thromboembolism: A randomised controlled trial, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2021-22), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2021-22), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada